Insmed (INSM) Gains from Investment Securities (2021 - 2026)

Insmed's Gains from Investment Securities history runs 6 years deep, the most recent figure standing at -$47.0 million for Q1 2026.

• On a quarterly basis, Gains from Investment Securities fell 356.62% year-over-year to -$47.0 million in Q1 2026; TTM through Mar 2026 was $186.7 million, a 53.21% increase from a year earlier, with the FY2025 full-year figure at $252.0 million, up 174.86% from the prior year.
• Gains from Investment Securities fell to -$47.0 million in Q1 2026 per INSM's latest filing, from $70.0 million in the prior quarter.
• Across five years, Gains from Investment Securities topped out at $104.7 million in Q3 2025 and bottomed at -$47.0 million in Q1 2026.
• The 5-year median for Gains from Investment Securities is $9.0 million (2023), against an average of $17.9 million.
• Across the five-year window, Gains from Investment Securities surged 972.22% in 2023 and sank 356.62% in 2026, its largest moves.
• Year by year, Gains from Investment Securities stood at -$1.8 million in 2022, then jumped by 972.22% to $15.7 million in 2023, then tumbled by 194.27% to -$14.8 million in 2024, then surged by 573.24% to $70.0 million in 2025, then plunged by 167.05% to -$47.0 million in 2026.
• Per Business Quant, the three latest INSM Gains from Investment Securities figures stand at -$47.0 million (Q1 2026), $70.0 million (Q4 2025), and $104.7 million (Q3 2025).